[ Price : $8.95]
FDA approves an expanded indication for Pfizer and Protalix BioTherapeutics Elelyso (taliglucerase alfa) for injection for treatin...[ Price : $8.95]
FDA approves an InnoPharma ANDA for decitabine for injection, a generic of Eisais Dacogne, indicated for treating patients with my...[ Price : $8.95]
The U.S. Department of Justice disputes a Pharmaceutical Research and Manufacturers of America brief asking a California federal c...[ Price : $8.95]
PhRMA calls on FDA to use notice-and-comment rulemaking for new regulations about communicating new information about both drug ri...[ Price : $8.95]
FDA lifts a partial clinical hold against OncoMed Pharmaceuticals and enrollment in its vantictumab (anti-Fzd7, OMP-18R5) Phase 1 ...[ Price : $8.95]
FDA denies a citizen petition seeking tighter bioequivalence recommendations for generic versions of Bristol-Myers Squibbs Megace ...[ Price : $8.95]
Tufts University researchers call for an update to the decades-old $50,000 quality-adjusted life-year (QALY) benchmark used in cos...[ Price : $8.95]
The National Council for Prescription Drug Programs tells FDA it has concerns about the agencys recent decision to give biological...